Ashraf: Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multi-center placebo-controlled randomized clinical trial

Ashraf, 313 patient nigella sativa early treatment RCT: 82% lower mortality [p=0.01], 84% improved recovery [p<0.0001], and 82% improved viral clearance [p<0.0001] https://c19p.org/ashraf2

copied to clipboard

Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multi-center placebo-controlled randomized clinical trial

Ashraf et al., medRxiv, doi:10.1101/2020.10.30.20217364 (Preprint), HNS-COVID-PK, NCT04347382 (history)

3 Nov 2020 Source PDF Share Tweet

RCT with 157 patients treated with honey and nigella sativa, and 156 control patients, showing significantly faster recovery and viral clearance.

Honey (1gm/kg/day) plus encapsulated nigella sativa seeds (80mg/kg/day) orally in 2-3 divided doses daily for up to 13 days.

Important missing comments or errors? Let us know.

risk of death, 81.9% lower, RR 0.18, p = 0.01, treatment 2 of 157 (1.3%), control 11 of 156 (7.1%), NNT 17, all cases.

risk of death, 67.1% lower, RR 0.33, p = 0.49, treatment 0 of 107 (0.0%), control 1 of 103 (1.0%), NNT 103, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), moderate cases.

risk of death, 78.8% lower, RR 0.21, p = 0.03, treatment 2 of 50 (4.0%), control 10 of 53 (18.9%), NNT 6.7, severe cases.

risk of no recovery, 83.6% lower, HR 0.16, p < 0.001, treatment 107, control 103, inverted to make RR<1 favor treatment, moderate cases.

risk of no recovery, 75.2% lower, HR 0.25, p < 0.001, treatment 50, control 53, inverted to make RR<1 favor treatment, severe cases.

risk of no viral clearance, 81.9% lower, HR 0.18, p < 0.001, treatment 107, control 103, inverted to make RR<1 favor treatment, moderate cases.

risk of no viral clearance, 76.9% lower, HR 0.23, p < 0.001, treatment 50, control 53, inverted to make RR<1 favor treatment, severe cases.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

Ashraf et al., 3 Nov 2020, Randomized Controlled Trial, Pakistan, preprint, 48 authors, this trial uses multiple treatments in the treatment arm (combined with honey) - results of individual treatments may vary, trial NCT04347382 (history) (HNS-COVID-PK).

All Studies Meta Analysis Submit Updates or Corrections

This Paper Nigella Sativa All

Please send us corrections, updates, or comments. Vaccines and treatments are both valuable and complementary. All practical, effective, and safe means should be used. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases mortality, morbidity, collateral damage, and the risk of endemic status. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit